1,598
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma

, , , &
Pages 7765-7779 | Received 27 Jul 2021, Accepted 21 Sep 2021, Published online: 07 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pengfei Li, Huina Lv, Yongkai Wu, Ke Xu, Min Xu & Yegang Ma. (2021) E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375. Bioengineered 12:2, pages 10047-10062.
Read now

Articles from other publishers (2)

Zhirui Zeng, Chujiao Hu, Wanyuan Ruan, Jinjuan Zhang, Shan Lei, Yushi Yang, Pailan Peng, Feng Pan & Tengxiang Chen. (2022) A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy. Frontiers in Immunology 13.
Crossref
Jianqiang Wei, Chunman Zhang, Liujia Ma & Chunrui Zhang. (2022) Artificial Intelligence Algorithm-Based Intraoperative Magnetic Resonance Navigation for Glioma Resection. Contrast Media & Molecular Imaging 2022, pages 1-8.
Crossref